1Erkan F, Gul A, Tasali E. Pulmonary manifestations of Behcet's disease. Thorax, 2001,56:572-578.
2Anonymous. International Study Group for Behcet's Disease. Criteria for diagnosis of Behcet's disease. Lancet, 1990, 335(8697): 1078-1080.
3Gunen H, Evereklioglu C, Kosar F, et al. Thoracic involvement in Behcet's disease and its correlation with multiple parameters. Lung,2000, 178(3): 161-170.
4Caterino U, Paciocco G, D'Auria D, et al. Subpleural lung involvement in Behcet's disease: first localization of a systemic entity.Monaldi Arch Chest Dis, 2000,55(4): 289-292.
5Misgav M, Goldberg Y, Zeltser D, et al. Fatal pulmonary artery thrombosis in a patient with Behcet's disease, activated protein C re-sistance and hyperhomocystinemia. Blood Coagul Fibrinolysis, 2000,11(5): 421-423.
6Yasuo M, Nagano S, Yazaki Y, et al. Pulmonary embolism due to right ventricular thrombus in a case of Behcet's disease. Jpn Circ J,1999, 63(11): 909-911.
8Desbois A, Wechsler B, Resche Rigon M, et al. Immunosuppressants reduce venous thrombosis relapse in Behqet's disease. Arthritis Rheum. 2012 Feb 21. doi: 10. 1002/art. 34450. EEpub ahead of print].
9Mizuki N, Meguro A, Ota M, et al. Genome-wide association studies identify IL23R-IL12RB2 and ILl0 as Behet's disease susceptibili- ty loci. Nat Genet,2010 ,d2( 8 ) :703-706.
10Tursen U, Gurler A, Boyvat A. Evaluation of clinical findings ac- cording to sex in 2313 Turkish patients with Behet's disease. Int J Dermatol,2005,42(5) :346-351.
